JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (4): 60-63.doi: 10.6040/j.issn.1673-3770.0.2016.362
Previous Articles Next Articles
ZHAO Jincheng, SHI Ying, ZHANG Ying, JIA Zhanhong, MA Xin, ZHANG Jingqiu, WU Zaijun, WANG Yu
CLC Number:
[1] Schmitz S, Machiels JP. Molecular biology of squamous cell carcinoma of the head and neck relevance and therapeutic implications[J]. Expert Rev Anticancer Ther, 2010, 10(9):1471-1484. [2] Rezende TM, De Souza Freire M, Franco OL. Head and neck cancer: Proteomic advances and biomarker achievements[J]. Cancer, 2010, 116(21):4914-4925. [3] Chen CY, Huang CC, Cheng JT, et al. The clincopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngealcancer[J]. Cancer Lett, 2003, 201(2):217-223. [4] Poetsch M, Lorenz G, Kleist B. Detection of new PTEN/MMAC1 mutation in head and neck squamous cell carcinoma with loss ofchromosome10[J]. Cancer Genet Cytogenet, 2002, 132(1):20-24. [5] Coppoia D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies[J]. Clin Cancer Res, 2004, 10(1):184-190. [6] Wu W, Tang X, Hu W, et al. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry[J]. Clin Exp Metastasis, 2002, 19(4):319-326. [7] Carvalho AL, Jeronimo C, Kim MM, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening /diagnosis tool for head and neck squamous cell carcinoma[J]. Clin Cancer Res, 2008, 14(1):97-107. [8] Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients[J]. Cancer Res, 2000, 60(4):892-895. [9] Kaur J, Demokan S, Tripathi SC. Promoter hypermethylation in Indian primary oral squamous cell carcinoma[J]. Int J Cancer, 2010, 127(10):2367-2373. [10] Wu JC, Santi DV. Kinetic and catalytic mechanism of HhaI methyltransferase[J]. J Biol Chem, 1987, 262(10):4778-4786. [11] 陈浩明, 梅晓春. 表观遗传现象[M] //薛京伦. 表观遗传学. 上海:上海科学技术出版社, 2006: 61-62. [12] Shen Z, Chen X, Li Q, et al. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients[J]. Clin Biochem, 2016, 49(16-17):1278-1282. [13] Lim Y, Wan Y, Vagenas D, et al. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers[J]. BMC Cancer, 2016, 16(1):749. [14] Gu X, Boldrup L, Coates PJ, et al. Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites[J]. Sci Rep, 2016, 6:32579. [15] Chen LH, Hsu WL, Tseng YJ, et al. Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines[J]. BMC Cancer, 2016, 16:431. [16] Scarpa M, Scarpa M, Castagliuolo I, et al. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC[J]. Oncotarget, 2016, 7(9):10322-10331. [17] Sheng Y, Wang H, Liu D, et al. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma[J]. Gynecol Oncol, 2016, 140(1):145-151. [18] Huang KT, Mikeska T, Li J, et al. Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour[J]. BMC Cancer, 2015, 15:669. [19] Kitamoto A, Kitamoto T, Nakamura T, et al. CDH13 polymorphisms are associated with adiponectin levels and metabolic syndrome traits independently of visceral fat mass[J]. J Atheroscler Thromb, 2016, 23(3):309-319. [20] Cho CH, Lee HJ, Woo HG, et al. CDH13 and HCRTR2 may be associated with hypersomnia symptom of bipolar depression:a genome-wide functional enrichment pathway analysis[J]. Psychiatry Investig, 2015, 12(3):402-407. |
[1] | WU Jing, LIU Yehai. Targeted therapy for head and neck squamous cell carcinoma [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 97-102. |
[2] | ZHANG Mingde, ZHANG Zuping, YU Xuemin, WEI Yanhong, YUAN Ying. RASSF2A methylation in laryngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 64-67. |
[3] | JIN Jian-ping. Expression of MCP-1 and BMP-7 in auricular keloid [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(6): 35-37. |
[4] | LI Xue-zhen1, JIN Xiao-ming1, LIU Min-sheng2. Expression and clinicopathological significance of Notch-1,NF-kB and β-catenin in oral squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(1): 9-13. |
[5] | L Mei1, DONG Pin2, SHE Cui-ping3, DU Cui-ping1, LI Yong1, XU Er-dong1. Differentially expressed genes in 3 cases of hypopharyngeal carcinoma and normal tissues by cDNA microarray [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(5): 5-. |
[6] | HUANG Fang, KANG Rui. Abnormal expression of PI3Kp85 in nasopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(3): 17-20. |
[7] |
ZHANG Jian-li,WANG Yue-jian,CHEN Wei-xiong,HU Wei-wei,LI Guang-min .Immunohistochemistry and serial section in detection of lymph node micrometastasis of head and neck squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(4): 299-303 . |
[8] | LIU Rui,SHI Wen-jie,LIU Ji-xiang . Differentially expressed genes in laryngeal squamous cell carcinoma and normal tissue by cDNA microarray [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(1): 68-70 . |
|